Centessa Pharmaceuticals (CNTA)
(Delayed Data from NSDQ)
$9.47 USD
-0.08 (-0.84%)
Updated May 3, 2024 04:00 PM ET
After-Market: $9.47 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/10/24 |
---|---|
Current Quarter | -0.41 |
EPS Last Quarter | -0.38 |
Last EPS Surprise | 13.64% |
ABR | 1.57 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.83 |
Next Year | -1.70 |
EPS (TTM) | -1.57 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | 6.85M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.41 | -0.45 | -1.83 | -1.70 |
# of Estimates | 2 | 2 | 3 | 3 |
Most Recent Consensus | -0.43 | -0.49 | -2.01 | -1.88 |
High Estimate | -0.39 | -0.40 | -1.61 | -1.60 |
Low Estimate | -0.43 | -0.49 | -2.01 | -1.88 |
Year ago EPS | -0.53 | -0.26 | -1.57 | -1.83 |
Year over Year Growth Est. | 22.64% | -73.08% | -16.56% | 7.28% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.41 | -0.45 | -1.83 | -1.70 |
7 Days Ago | -0.41 | -0.45 | -1.83 | -1.70 |
30 Days Ago | -0.41 | -0.45 | -1.83 | -1.70 |
60 Days Ago | NA | NA | -1.70 | -1.62 |
90 Days Ago | NA | NA | -1.70 | -1.62 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.41 | -0.45 | -1.83 | -1.70 |
Zacks Consensus Estimate | -0.41 | -0.45 | -1.83 | -1.70 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.38 | -0.40 | -0.26 | -0.53 | NA |
Estimate | -0.44 | -0.46 | -0.43 | -0.39 | NA |
Difference | 0.06 | 0.06 | 0.17 | -0.14 | 0.04 |
Surprise | 13.64% | 13.04% | 39.53% | -35.90% | 7.58% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more